Back to Results
First PageMeta Content
Organ failure / Hypertension / Blood pressure / Antihypertensive drug / Genomics / Heart failure / ACE inhibitor / Cardiovascular disease / Stroke / Aging-associated diseases / Health / Anatomy


Developing first in class cardiovascular drugs Disclaimer This document has been prepared by Quantum Genomics (“the Company”) solely for use at this presentation. By receiving this presentation and taking part to th
Add to Reading List

Document Date: 2015-03-04 09:18:14


Open Document

File Size: 2,10 MB

Share Result on Facebook

Company

AMF / Quantum Genomics / /

Continent

Europe / /

Country

France / Japan / United States / Canada / Australia / /

Currency

USD / /

Facility

Robust pipeline / /

IndustryTerm

applicable securities law / prevention of cardiovascular disease / internet websites / /

MedicalCondition

Circulation Heart Failure / hypertension / stroke / heart disease / cardiovascular disease / diabetes / high cholesterol / Uncontrolled hypertension Hypertension / kidney failure / obesity / diseases / high blood pressure / cardiovacular diseases / blindness / Global heart failure / /

NaturalFeature

Calcium Channel / /

Organization

World Health Organization / College de France / Efficient / /

Person

Margaret Chan / /

Position

Director of the Central Neuropeptides and / Chief / /

URL

www.amf-france.org / www.quantumgenomics.com / www.quantum-genomics.com / /

SocialTag